“ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS” (2012) Mediterranean Journal of Hematology and Infectious Diseases, 4(1), p. e2012072. doi:10.4084/mjhid.2012.072.